News

Sage received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for SAGE-217 in MDD in February 2018, and recently announced an expedited development plan for

The trials, named GEMINI-1 and GEMINI-2, assessed the 2DR against a three-drug regimen of dolutegravir and two nucleoside reverse transcriptase inhibitors in HIV-1 patients with baseline viral loads

The acquisition of Sanofi’s manufacturing centre and business located in Holmes Chapel provides Recipharm with a solid platform to take further advantage of the growing respiratory drug market.

Roche chief medical officer and global product development head Sandra Horning said: “Today’s approval is an important advance for women newly diagnosed with this type of ovarian cancer.

The Boston-based clinical-stage biotechnology company had been conducting the mid-stage trials for the oral disintegrating tablet formulation in amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth (CMT). Flex Pharma said

PFIC is a rare and life-threatening liver disease with no approved pharmacologic treatment option. A4250 is an ileal bile acid transporter (IBAT) inhibitor, which is being developed for

These two trials, KF7013-02 and KF7013-04, are investigating the efficacy and safety of neridronate in 360 patients with CRPS. Neridronate, a bisphosphonate, is an innovative investigational medicine discovered

Ganovo is the first Direct-acting Anti-viral Agent (DAA) developed by a domestic company in China and has been selected as a National Science and Technology Major Project for

The approval has been given for treatment of patients whose tumors express PD-L1 [Combined Positive Score (CPS) ≥1] as determined by an FDA-approved test. Merck said that the